Microviable Therapeutics SL services

Analyses of the composition and functionality of the intestinal microbiota using next generation sequencing technologies (NGS) coupled with advance bioinformatics. The intestinal microbiota is a complex microbial community that live with and inside us (inhabit our gastrointestinal tract) and carries out many functions such as protection against pathogens, modulation of the immune system and production of essential components. The alteration of the microbiota (dysbiosis) has been associated with several illnesses, C. difficile infection, IBD, Crohn’s disease, and medical treatments like antibiotic therapy, chemotherapy, radiotherapy.

Next generation biotherapeutics based on complex consortia from intestinal microbiota. Our revolutionary product GutAlive® together with our in-house technology bring us to the next level on biotherapeutics development. We can now isolate and store intestinal microbiota in viable conditions, to study and understand the microbes that have a key role in human health. This pipeline enables us to develop next generation biotherapeutics based on complex consortia from intestinal microbiota that can be used to improve human health.

We offer the possibility to isolate and store your intestinal microbiota in viable conditions, under the highest standards of quality and privacy, to be used in the future to restore your intestinal microbiota in case of dysbiosis.